1. Butrov А.V., Borisov А.Yu., Galenko S.V. Regional infusion therapy in critically ill patients. Trudny Patsient, 2006, vol. 4, no. 10, pp. 19-23. (In Russ.)
2. Goldina O.А., Gorbachevskiy Yu.V. Advantage of modern hydroxyethylated starch agents among other plasma-substituting infusion solutions. Vestnik Sluzhby Krovi Rossii, 1998, no. 3, pp. 41-45. (In Russ.)
3. European Medicine Agency. EMA/35795/2018. January 26, 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2018/01/WC500242423.pdf
4. Kulabukhov V.V. Sistema transporta kisloroda u bolnykh v kriticheskikh sostoyaniyakh (predposylki k prognozirovaniyu iskhoda bolezni). Diss. kand. med. nauk. [Oxygen transportation system in critically ill patients (factors for disease outcome prognosis). Cand. Diss.]. Moscow, 2006, 287 p.
5. Selektivnaya plazmofiltratsiya fraktsionatorami plazmy Evaclio™ u patsientov s sindromom mekhanicheskoy zheltukhi. Prakt. ruk-vo. [Selective plasma filtration by the plasma fractionator of Evaclio™ in the patients with obstructive jaundice. Manual]. V.V. Kulabukhov, eds., Moscow, NPF POKARD Publ., 2016, 27 p.